Carcinogen-derived biomarkers and lung cancer

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


Carcinogen-derived biomarkers are substances such as metabolites or macromolecular adducts that are derived from specific identifiable carcinogens and can be quantified in human tissues or body fluids. With respect to lung cancer, the most important carcinogen-derived biomarkers presently being studied are those derived from the lung carcinogens in tobacco smoke-4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and polynuclear aromatic hydrocarbons. Some examples of these biomarkers and their application are discussed.

Original languageEnglish (US)
Pages (from-to)7-9
Number of pages3
JournalPreventive medicine
Issue number1
StatePublished - Jan 1996

Bibliographical note

Funding Information:
2Our work on carcinogen-derived biomarkers is supported by Grants CA-29580 and CA-44377 from the National Cancer Institute.


Dive into the research topics of 'Carcinogen-derived biomarkers and lung cancer'. Together they form a unique fingerprint.

Cite this